Egret Therapeutics completes oversubscribed pre-A financing round

/PRNewswire/ -- Egret Therapeutics, a clinical-stage biotherapeutics company focused on the treatment of neurological diseases, announced today the completion...

Related Keywords

Jaemoon Lee ,Daniel Chai ,Christopher Jackson ,Fascinate Therapeutics Inc ,Chairperson Of Neurosurgery At Stanford Medical Center ,Egret Therapeutics ,Turret Capital Management ,Delayed Cerebral Ischemia ,Turret Capital ,Michael Lim ,Stanford Medical Center ,Assistant Professor ,Johns Hopkins Medical ,